Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-16-130107
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-29 17:27:35
Reporting Period:
2016-06-27
Filing Date:
2016-06-29
Accepted Time:
2016-06-29 17:27:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178711 Paratek Pharmaceuticals Inc. PRTK Pharmaceutical Preparations (2834) 330960223
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1623720 J. Richard Lim C/o Paratek Pharmacuticals, Inc.
75 Kneeland Street
Boston MA 02111
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-27 384,615 $13.00 779,802 No 4 P Indirect By Omega Fund IV, L.P.
Common Stock Acquisiton 2016-06-27 76,923 $13.00 1,187,365 No 4 P Indirect By Omega Fund III, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Omega Fund IV, L.P.
No 4 P Indirect By Omega Fund III, L.P.
Footnotes
  1. These securities are held in the name of Omega Fund IV, L.P. ("Omega IV"). The Reporting Person is a director of Omega Fund IV GP Manager, Ltd., the general partner of Omega Fund IV GP, L.P., which is the general partner of Omega IV, and has shared voting and investment power over, and a proportionate pecuniary interest in, the shares held by Omega IV. The Reporting Person disclaims beneficial ownership of the securities held by Omega IV except to the extent of his proportionate pecuniary interest therein.
  2. These securities are held in the name of Omega Fund III, LP. ("Omega III"). Omega Fund III GP, L.P. ("Omega III GP LP") is the general partner of Omega III. Omega Fund III G.P., Ltd. ("Omega III GP") is the general partner of Omega III GP LP. Clessidra, LLC ("Clessidra") is the sole shareholder of Omega III GP. Omega III, Omega III GP LP, Omega III GP, Clessidra, Danish BV and Danish BV GP are collectively referred to as the "Omega Funds". As a result of an understanding relating to the Omega Funds, the Reporting Person may have an indirect pecuniary interest in the securities held by Omega III. The Reporting Person disclaims beneficial ownership of the securities held by Omega III except to the extent of his pecuniary interest therein.